CureVac N.V.
NASDAQ:CVAC
4.07 (USD) • At close January 15, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 493.902 | 14.436 | 12.373 | 21.988 | 16.483 | 7.579 | 7.129 | 11.689 | 11.212 | 20.146 | 24.373 | 41.225 | 29.34 | 22.395 | 10.03 | 6 | 5.162 | 34.549 | 3.119 | 6.816 | 1.096 | 3.156 |
| Cost of Revenue
| 21.931 | 40.723 | 41.689 | 59.763 | 24.281 | 25.854 | 20.635 | 80.001 | 24.079 | 42.681 | 37.232 | 70.018 | 115.021 | 37.396 | 15.76 | 7.124 | 1.973 | 0.399 | 5.475 | 9.111 | 6.999 | 7.558 |
| Gross Profit
| 471.971 | -26.287 | -29.316 | -37.775 | -7.798 | -18.275 | -13.506 | -68.312 | -12.867 | -22.535 | -12.859 | -28.793 | -85.681 | -15.001 | -5.73 | -1.124 | 3.189 | 34.15 | -2.356 | -2.295 | -5.903 | -4.402 |
| Gross Profit Ratio
| 0.956 | -1.821 | -2.369 | -1.718 | -0.473 | -2.411 | -1.895 | -5.844 | -1.148 | -1.119 | -0.528 | -0.698 | -2.92 | -0.67 | -0.571 | -0.187 | 0.618 | 0.988 | -0.755 | -0.337 | -5.386 | -1.395 |
| Reseach & Development Expenses
| 49.979 | 31.093 | 27.825 | 29.373 | 27.245 | 30.868 | 24.251 | 27.616 | 12.512 | 11.636 | 10.786 | 531.179 | 48.461 | 131.281 | 104.986 | 37.471 | 34.57 | 30.866 | 10.902 | 12.577 | 5.349 | 10.862 |
| General & Administrative Expenses
| 14.063 | 13.372 | 16.694 | 21.596 | 15.836 | 18.98 | 19.597 | 23.566 | 21.985 | 23.115 | 20.328 | 14.095 | 22.455 | 31.229 | 19.422 | 11.882 | 9.422 | 13.981 | 9.744 | 13.679 | 9.124 | 5.471 |
| Selling & Marketing Expenses
| 0.174 | 0.075 | 0.105 | 0.082 | 0.145 | 0.088 | 0.108 | 0.097 | 0.093 | -0.044 | 0.271 | 0.511 | 0.203 | 0.552 | 0.477 | -0.076 | -0.2 | 0.679 | 0.33 | 1.27 | -0.024 | 0.198 |
| SG&A
| 14.237 | 13.447 | 16.799 | 23.253 | 15.981 | 19.068 | 19.705 | 23.663 | 22.078 | 23.071 | 20.599 | 14.606 | 22.658 | 31.781 | 19.899 | 11.806 | 9.222 | 14.66 | 10.074 | 14.949 | 9.1 | 5.669 |
| Other Expenses
| 39.376 | 2.793 | 0 | 0 | 0 | 0 | 3.203 | 2.394 | 4.923 | 3.977 | -28.976 | -569.067 | -13.706 | -30.238 | -14.782 | -3.719 | -3.845 | -7.377 | -0.117 | 5.249 | -1.207 | 0.792 |
| Operating Expenses
| 103.592 | 47.333 | 44.923 | 52.626 | 46.713 | 53.702 | 47.159 | 53.673 | 39.513 | 38.684 | 2.409 | -23.282 | 57.413 | 132.824 | 110.103 | 52.6 | 39.947 | 38.149 | 20.859 | 32.775 | 13.242 | 17.323 |
| Operating Income
| 368.379 | -73.62 | -73.317 | -90.401 | -54.036 | -71.801 | -60.355 | -121.51 | -52.38 | -60.299 | -15.268 | -5.511 | -143.094 | -147.825 | -115.833 | -46.6 | -36.758 | -3.2 | -23.216 | -35.071 | -19.145 | -21.725 |
| Operating Income Ratio
| 0.746 | -5.1 | -5.926 | -4.111 | -3.278 | -9.474 | -8.466 | -10.395 | -4.672 | -2.993 | -0.626 | -0.134 | -4.877 | -6.601 | -11.549 | -7.767 | -7.121 | -0.093 | -7.443 | -5.145 | -17.468 | -6.884 |
| Total Other Income Expenses Net
| 2.193 | 2.377 | 3.43 | 1.526 | 5.361 | 4.414 | 2.937 | -7.24 | 4.735 | 2.728 | 0.079 | 0.952 | -0.418 | -4.368 | 3.599 | -10.617 | 0.068 | -8.807 | -0.678 | -0.836 | 0.141 | 0.559 |
| Income Before Tax
| 370.572 | -71.243 | -69.887 | -84.269 | -48.675 | -67.387 | -57.418 | -128.75 | -47.646 | -57.57 | -15.189 | -4.559 | -143.512 | -152.193 | -112.234 | -57.3 | -36.69 | -12.007 | -23.894 | -35.907 | -19.004 | -21.166 |
| Income Before Tax Ratio
| 0.75 | -4.935 | -5.648 | -3.832 | -2.953 | -8.891 | -8.054 | -11.015 | -4.25 | -2.858 | -0.623 | -0.111 | -4.891 | -6.796 | -11.19 | -9.55 | -7.108 | -0.348 | -7.661 | -5.268 | -17.339 | -6.707 |
| Income Tax Expense
| 32.529 | 1.301 | 0.666 | 0.161 | 0.006 | 0.026 | 0.001 | 0.034 | -0.078 | 0.014 | -0.096 | -2.623 | 0.512 | -0.137 | 1.466 | 0.889 | 0.144 | -1.716 | -0.044 | 0.083 | -0.644 | 0.142 |
| Net Income
| 338.043 | -72.543 | -70.553 | -84.43 | -48.681 | -67.414 | -57.419 | -128.784 | -47.568 | -57.584 | -15.093 | -1.936 | -144.024 | -152.056 | -113.7 | -57.3 | -36.834 | -10.291 | -23.85 | -35.99 | -18.36 | -21.308 |
| Net Income Ratio
| 0.684 | -5.025 | -5.702 | -3.84 | -2.953 | -8.895 | -8.054 | -11.018 | -4.243 | -2.858 | -0.619 | -0.047 | -4.909 | -6.79 | -11.336 | -9.55 | -7.136 | -0.298 | -7.647 | -5.28 | -16.752 | -6.752 |
| EPS
| 0 | -0.32 | -0.31 | -0.38 | -0.22 | -0.3 | -0.27 | -0.66 | -0.26 | -0.31 | -0.082 | -0.011 | -0.8 | -0.84 | -0.62 | -0.32 | -0.2 | -0.059 | -0.14 | -0.2 | -0.1 | -0.12 |
| EPS Diluted
| 0 | -0.32 | -0.31 | -0.38 | -0.22 | -0.3 | -0.27 | -0.66 | -0.26 | -0.31 | -0.082 | -0.011 | -0.8 | -0.84 | -0.61 | -0.32 | -0.2 | -0.057 | -0.14 | -0.2 | -0.1 | -0.12 |
| EBITDA
| 375.225 | -65.962 | -72.221 | -81.32 | -38.68 | -59.968 | -56.356 | -125.906 | -40.406 | -49.402 | -4.17 | -21.197 | -136.843 | -144.083 | -105.656 | -57.608 | -32.885 | -3.012 | -23.007 | -37.371 | -17.723 | -20.695 |
| EBITDA Ratio
| 0.76 | -4.569 | -5.302 | -3.698 | -2.376 | -7.936 | -7.143 | -10.812 | -3.604 | -2.452 | -0.171 | 0.002 | -4.664 | -6.434 | -10.534 | -7.767 | -6.371 | -0.087 | -6.523 | -5.483 | -16.171 | -6.183 |